Teratogenesis of sodium valproate
- 1 April 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 20 (2), 175-180
- https://doi.org/10.1097/wco.0b013e32805866fb
Abstract
Sodium valproate has been a first-line antiepileptic drug for 40 years. A recent multicentre study conducted in the UK (Standard and New Antiepileptic Drugs) has confirmed what most practising neurologists had long suspected – that sodium valproate is the most effective drug in the treatment of idiopathic generalized epilepsy and juvenile myoclonic epilepsy. Knowledge of the drug's unsurpassed efficacy has intensified the dilemma faced by neurologists treating people with epilepsy, and in particular young women. Recent data from pregnancy registers has not only confirmed that sodium valproate is teratogenic but also that it may be associated with neurodevelopmental delay and autistic spectrum disorders in the children of women exposed to the drug during pregnancy. Thus physicians have to balance the undoubted benefits of seizure freedom for their female patients with the potential long-term consequences for the infants of these patients. There is undoubtedly a phamacogenetic component to sodium valproate's teratogenic and neurodevelopmental effects. Future research may enable us to identify those women whose offspring may be affected. Research now underway will help quantify the precise risk of neurodevelopmental delay in the offspring of women exposed to the drug, although it will be some years before results become available.Keywords
This publication has 28 references indexed in Scilit:
- Antiepileptic drug use of women with epilepsy and congenital malformations in offspringNeurology, 2005
- Increased rate of major malformations in offspring exposed to valproate during pregnancyNeurology, 2005
- The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 monthsJournal of Clinical Neuroscience, 2003
- Selection bias in Teratology Information Service pregnancy outcome studiesTeratology, 2001
- Congenital malformations due to antiepileptic drugsEpilepsy Research, 1999
- Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal EpilepsyEpilepsia, 1997
- Prevention of stroke with ticlopidineNeurology, 1992
- IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1986
- VALPROIC ACID AND SPINA BIFIDAThe Lancet, 1982
- MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTSThe Lancet, 1982